Timo Möttönen

Medicine · Health Sciences

41h-index6.8kcitations153works20.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(85), Systemic Lupus Erythematosus Research(40), Autoimmune and Inflammatory Disorders Research(21), Chronic Lymphocytic Leukemia Research(15), Spondyloarthritis Studies and Treatments(13)

Publications153 total

Association between postoperative thromboembolic and hemorrhagic complications and clinical outcomes after surgery for chronic subdural hematoma in patients with anticoagulation therapy for atrial fibrillation
Acta Neurochirurgica·2025· 6 citedOpen Access
Burr-hole drainage with or without irrigation for chronic subdural haematoma (FINISH): a Finnish, nationwide, parallel-group, multicentre, randomised, controlled, non-inferiority trial
The Lancet·2024· 35 cited
Cervical Spine Involvement among Patients with Rheumatoid Arthritis Treated Actively with Treat-to-target Strategy: 10-year Results of the NEO-RACo Study
The Journal of Rheumatology·2019· 17 cited
Early Targeted Combination Treatment With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs and Long‐Term Outcomes in Rheumatoid Arthritis: Ten‐Year Follow‐Up Results of a Randomized Clinical Trial
Arthritis Care & Research·2018· 7 citedOpen Access
Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial
PLoS ONE·2017· 39 citedOpen Access
Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials.
PubMed·2017· 8 cited
Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial.
PubMed·2017· 6 cited
Influence of triple disease modifying anti-rheumatic drug therapy on carotid artery inflammation in drug-naive patients with recent onset of rheumatoid arthritis
Lara D. Veeken·2016· 10 citedOpen Access
Long-Term Real-Life Experience With Rituximab in Adult Finnish Patients With Rheumatoid Arthritis Refractory or With Contraindication to Anti–Tumor Necrosis Factor Drugs
JCR Journal of Clinical Rheumatology·2015· 11 cited
Failure in Longterm Treatment is Rare in Actively Treated Patients with Rheumatoid Arthritis, But May Be Predicted by High Health Assessment Score at Baseline and by Residual Disease Activity at 3 and 6 Months: The 5-year Followup Results of the Randomized Clinical NEO-RACo Trial
The Journal of Rheumatology·2014· 7 citedOpen Access
FRI0254 Predictive Value of Pretreatment Resistin Levels for Erosive Disease in Early RA Treated with DMARDS and Infliximab
Annals of the Rheumatic Diseases·2014
A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland
Scandinavian Journal of Rheumatology·2014· 6 cited
Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial
Annals of the Rheumatic Diseases·2013· 16 cited
Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial
Annals of the Rheumatic Diseases·2013· 54 cited
SAT0026 Targeted Treatment and Combination Dmard Therapy are Additively Important for Reaching Remission in Early Rheumatoid Arthritis
Annals of the Rheumatic Diseases·2013
SAT0027 Targeted Treatment and Combination Dmard Therapy are Additively Important for Maintaining Work Ability in Early Rheumatoid Arthritis
Annals of the Rheumatic Diseases·2013
FRI0540 A nation-wide review of patients with rheumatoid arthritis in finland
Annals of the Rheumatic Diseases·2013
Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis.
PubMed·2013· 14 cited
Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial
Annals of the Rheumatic Diseases·2013· 1 cited
Combination therapy in rheumatoid arthritis
2012
page 1 of 8Next →

Frequent Co-authors

Pekka Hannonen(25), Hannu Kautiainen(19), Marjatta Leirisalo‐Repo(17), Markku Korpela(14), Reijo Luukkainen(13), Marjo Lehtonen-Veromaa(11), Leena Laasonen(8), Kari Puolakka(8), Kerttu Irjala(7), Leena Paimela(6), Harri Blåfield(6), Jorma Viikari(6), Olli J. Heinonen(6), Markku Hakala(5), Anna Karjalainen(5), Markku Kauppi(5), Paavo Toivanen(5), Heikki Julkunen(4), Mikko Hakola(4), Ilpo Nuotio(4)